EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and In Vitro Characterization of [3H]GMC-058 as Radioligand for Imaging Parkinsonian-Related Proteinopathies

Andrea Varrone iD, Vasco C Sousa iD, Manolo Mugnaini, Sandra Biesinger, Gunnar Nordvall iD, Lee Kingston, Ileana Guzzetti, Charles S Elmore iD, Dan Sunnemark iD, Dinahlee Saturnino Guarino iD, Sjoerd J Finnema iD, Magnus Schou

Cells · 2025

DOI: 10.3390/cells14120869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Andrea Varrone und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm Health Services, BioClinicum, J4-14, Akademi…. Hauptthemen laut MEDLINE: Parkinson Disease, alpha-Synuclein, Radiopharmaceuticals. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Swedish Parkinson Foundation (Parkinsonfonden), Michael J Fox Foundation for Parkinson Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The molecular imaging of α-synuclein (α-syn) pathology in Parkinson’s disease (PD) and related movement disorders is a clinically unmet need. The aim of this study was to discover and characterize in vitro a radioligand for imaging α-syn pathology. A library of 78 small molecules was developed and screened using recombinant α-syn fibrils and brain homogenates from Alzheimer’s disease (AD) donors. The selection criteria were as follows: Kiα-syn < 30 nM, Kitau and KiA-β > 200 nM. Three compounds, GMC-073 (Kiα-syn: 8 nM), GMC-098 (Kiα-syn: 9.7 nM), and GMC-058 (Kiα-syn: 22.5 nM), fulfilled the criteria and were radiolabeled with 3H. [3H]GMC-058 was the only compound with negligible binding in controls, and was further evaluated using tissue microarrays, autoradiography on fresh-frozen brain slices, and in vitro saturation binding assay on brain homogenates. [3H]GMC-058 binding co-localized with α-syn inclusions in Parkinson’s disease (PD) and multiple-system atrophy (MSA), with dense A-β plaques in cerebral amyloid angiopathy and AD and with p-tau inclusions in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Specific binding was highest in PSP and CBD. In vitro KD was highest in AD (5.4 nM), followed by PSP (41 nM) and CBD (75 nM). The KD in MSA, PD, and controls was >100 nM. [3H]GMC-058 is a novel radioligand displaying a low affinity for aggregated α-syn in tissue, with an in vitro profile also suitable for detecting tau pathology in 4R tauopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson Diseasealpha-SynucleinRadiopharmaceuticalsHumansBrainAgedAlzheimer DiseaseMaleAutoradiographyLigandsFemale

Stichwörter der Autor:innen

Lewy bodiesin vitro assayneurodegenerationproteinopathy

Substanzen

alpha-SynucleinLigandsRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm Health Services, BioClinicum, J4-14, Akademiska Stråket 1, 17176 Solna, Sweden.
  • Department of Clinical Neuroscience, Division of Imaging Core Facilities, Karolinska Institutet, Stockholm, Sweden, BioClinicum, J5, Akademiska Stråket 1, 17176 Solna, Sweden.
  • Translational Sciences, Neuroscience & Ophthalmology Discovery Research, AbbVie Deutschland GmbH & Co. KG, Knollstraße 50, 67061 Ludwigshafen, Germany.
  • Advanced Cell Technologies & Screening, Neuroscience & Ophthalmology Discovery Research, AbbVie Deutschland GmbH & Co. KG, Knollstraße 50, 67061 Ludwigshafen, Germany.
  • AlzeCure Pharma AB, Hälsovägen 7, 14157 Huddinge, Sweden.
  • Isotope Chemistry, Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden.

ORCID-Profile: Andrea Varrone, Vasco C Sousa, Gunnar Nordvall, Charles S Elmore, Dan Sunnemark, Dinahlee Saturnino Guarino, Sjoerd J Finnema

Förderung

  • NINDS NIH HHS
  • Swedish Parkinson Foundation (Parkinsonfonden)
  • Michael J Fox Foundation for Parkinson Research
  • NIH

Zitieren

APA

Varrone, A., Sousa, V. C., Mugnaini, M., Biesinger, S., Nordvall, G., Kingston, L., Guzzetti, I., Elmore, C. S., Sunnemark, D., Saturnino Guarino, D., Finnema, S. J., & Schou, M. (2025). Development and In Vitro Characterization of [3H]GMC-058 as Radioligand for Imaging Parkinsonian-Related Proteinopathies. Cells. https://doi.org/10.3390/cells14120869

Vancouver

Varrone A, Sousa VC, Mugnaini M, Biesinger S, Nordvall G, Kingston L, et al. Development and In Vitro Characterization of [3H]GMC-058 as Radioligand for Imaging Parkinsonian-Related Proteinopathies. Cells. 2025. doi:10.3390/cells14120869

BibTeX
@article{Varrone2025,
  author = {Varrone, Andrea and Sousa, Vasco C and Mugnaini, Manolo and Biesinger, Sandra and Nordvall, Gunnar and Kingston, Lee and Guzzetti, Ileana and Elmore, Charles S and Sunnemark, Dan and Saturnino Guarino, Dinahlee and Finnema, Sjoerd J and Schou, Magnus},
  title = {Development and In Vitro Characterization of [3H]GMC-058 as Radioligand for Imaging Parkinsonian-Related Proteinopathies},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14120869}
}
Kostenlos starten →